{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:13:45Z","timestamp":1791213225389,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"27","license":[{"start":{"date-parts":[[2013,8,12]],"date-time":"2013-08-12T00:00:00Z","timestamp":1376265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,8,12]],"date-time":"2013-08-12T00:00:00Z","timestamp":1376265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2014,7,3]]},"DOI":"10.1038\/onc.2013.320","type":"journal-article","created":{"date-parts":[[2013,8,12]],"date-time":"2013-08-12T10:15:23Z","timestamp":1376302523000},"page":"3571-3582","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["LIM domain kinases as potential therapeutic targets for neurofibromatosis type 2"],"prefix":"10.1038","volume":"33","author":[{"given":"A","family":"Petrilli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Copik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Posadas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L-S","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D B","family":"Welling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Giovannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Fern\u00e1ndez-Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,12]]},"reference":[{"key":"BFonc2013320_CR1","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/363515a0","volume":"363","author":"GA Rouleau","year":"1993","unstructured":"Rouleau GA, Merel P, Lutchman M, Sanson M, Zucman J, Marineau C et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 1993; 363: 515\u2013521.","journal-title":"Nature"},{"key":"BFonc2013320_CR2","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1016\/S0140-6736(09)60259-2","volume":"373","author":"AR Asthagiri","year":"2009","unstructured":"Asthagiri AR, Parry DM, Butman JA, Kim HJ, Tsilou ET, Zhuang Z et al. Neurofibromatosis type 2. Lancet 2009; 373: 1974\u20131986.","journal-title":"Lancet"},{"key":"BFonc2013320_CR3","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1212\/WNL.59.2.290","volume":"59","author":"ME Baser","year":"2002","unstructured":"Baser ME, De Rienzo A, Altomare D, Balsara BR, Hedrick NM, Gutmann DH et al. Neurofibromatosis 2 and malignant mesothelioma. Neurology 2002; 59: 290\u2013291.","journal-title":"Neurology"},{"key":"BFonc2013320_CR4","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1056\/NEJMoa0902579","volume":"361","author":"SR Plotkin","year":"2009","unstructured":"Plotkin SR, Stemmer-Rachamimov AO, Barker FG 2nd, Halpin C, Padera TP, Tyrrell A et al. Hearing improvement after bevacizumab in patients with neurofibromatosis type 2. N Engl J Med 2009; 361: 358\u2013367.","journal-title":"N Engl J Med"},{"key":"BFonc2013320_CR5","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s00401-011-0905-0","volume":"123","author":"M Kalamarides","year":"2012","unstructured":"Kalamarides M, Acosta MT, Babovic-Vuksanovic D, Carpen O, Cichowski K, Evans DG et al. Neurofibromatosis 2011: a report of the Children\u2019s Tumor Foundation annual meeting. Acta Neuropathol 2012; 123: 369\u2013380.","journal-title":"Acta Neuropathol"},{"key":"BFonc2013320_CR6","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/embor.2012.11","volume":"13","author":"W Li","year":"2012","unstructured":"Li W, Cooper J, Karajannis MA, Giancotti FG . Merlin: a tumour suppressor with functions at the cell cortex and in the nucleus. EMBO Rep 2012; 13: 204\u2013215.","journal-title":"EMBO Rep"},{"key":"BFonc2013320_CR7","doi-asserted-by":"publisher","first-page":"471","DOI":"10.2174\/138920310791824011","volume":"11","author":"I Stamenkovic","year":"2010","unstructured":"Stamenkovic I, Yu Q . Merlin, a \u2018magic\u2019 linker between extracellular cues and intracellular signaling pathways that regulate cell motility, proliferation, and survival. Curr Protein Pept Sci 2010; 11: 471\u2013484.","journal-title":"Curr Protein Pept Sci"},{"key":"BFonc2013320_CR8","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1038\/sj.onc.1202141","volume":"17","author":"PD Pelton","year":"1998","unstructured":"Pelton PD, Sherman LS, Rizvi TA, Marchionni MA, Wood P, Friedman RA et al. Ruffling membrane, stress fiber, cell spreading and proliferation abnormalities in human schwannoma cells. Oncogene 1998; 17: 2195\u20132209.","journal-title":"Oncogene"},{"key":"BFonc2013320_CR9","doi-asserted-by":"publisher","first-page":"10394","DOI":"10.1074\/jbc.M200083200","volume":"277","author":"JL Kissil","year":"2002","unstructured":"Kissil JL, Johnson KC, Eckman MS, Jacks T . Merlin phosphorylation by p21-activated kinase 2 and effects of phosphorylation on merlin localization. J Biol Chem 2002; 277: 10394\u201310399.","journal-title":"J Biol Chem"},{"key":"BFonc2013320_CR10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S1534-5807(01)00009-0","volume":"1","author":"RJ Shaw","year":"2001","unstructured":"Shaw RJ, Paez JG, Curto M, Yaktine A, Pruitt WM, Saotome I et al. The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling. Dev Cell 2001; 1: 63\u201372.","journal-title":"Dev Cell"},{"key":"BFonc2013320_CR11","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1074\/jbc.C100553200","volume":"277","author":"GH Xiao","year":"2002","unstructured":"Xiao GH, Beeser A, Chernoff J, Testa JR . p21-Activated kinase links Rac\/Cdc42 signaling to merlin. J Biol Chem 2002; 277: 883\u2013886.","journal-title":"J Biol Chem"},{"key":"BFonc2013320_CR12","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/S1097-2765(03)00382-4","volume":"12","author":"JL Kissil","year":"2003","unstructured":"Kissil JL, Wilker EW, Johnson KC, Eckman MS, Yaffe MB, Jacks T . Merlin, the product of the Nf2 tumor suppressor gene, is an inhibitor of the p21-activated kinase, Pak1. Mol Cell 2003; 12: 841\u2013849.","journal-title":"Mol Cell"},{"key":"BFonc2013320_CR13","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1523\/JNEUROSCI.4865-05.2006","volume":"26","author":"Y Nakai","year":"2006","unstructured":"Nakai Y, Zheng Y, MacCollin M, Ratner N . Temporal control of Rac in Schwann cell-axon interaction is disrupted in NF2-mutant schwannoma cells. J Neurosci 2006; 26: 3390\u20133395.","journal-title":"J Neurosci"},{"key":"BFonc2013320_CR14","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1038\/sj.onc.1210923","volume":"27","author":"C Thaxton","year":"2008","unstructured":"Thaxton C, Lopera J, Bott M, Fernandez-Valle C . Neuregulin and laminin stimulate phosphorylation of the NF2 tumor suppressor in Schwann cells by distinct protein kinase A and p21-activated kinase-dependent pathways. Oncogene 2008; 27: 2705\u20132715.","journal-title":"Oncogene"},{"key":"BFonc2013320_CR15","doi-asserted-by":"publisher","first-page":"7932","DOI":"10.1158\/0008-5472.CAN-08-0866","volume":"68","author":"C Yi","year":"2008","unstructured":"Yi C, Wilker EW, Yaffe MB, Stemmer-Rachamimov A, Kissil JL . Validation of the p21-activated kinases as targets for inhibition in neurofibromatosis type 2. Cancer Res 2008; 68: 7932\u20137937.","journal-title":"Cancer Res"},{"key":"BFonc2013320_CR16","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1002\/med.20230","volume":"32","author":"F Manetti","year":"2011","unstructured":"Manetti F . LIM kinases are attractive targets with many macromolecular partners and only a few small molecule regulators. Med Res Rev 2011; 32: 968\u2013998.","journal-title":"Med Res Rev"},{"key":"BFonc2013320_CR17","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/31735","volume":"393","author":"N Yang","year":"1998","unstructured":"Yang N, Higuchi O, Ohashi K, Nagata K, Wada A, Kangawa K et al. Cofilin phosphorylation by LIM-kinase 1 and its role in Rac-mediated actin reorganization. Nature 1998; 393: 809\u2013812.","journal-title":"Nature"},{"key":"BFonc2013320_CR18","doi-asserted-by":"publisher","first-page":"27569","DOI":"10.1074\/jbc.M504448200","volume":"280","author":"P Goyal","year":"2005","unstructured":"Goyal P, Pandey D, Behring A, Siess W . Inhibition of nuclear import of LIMK2 in endothelial cells by protein kinase C-dependent phosphorylation at Ser-283. J Biol Chem 2005; 280: 27569\u201327577.","journal-title":"J Biol Chem"},{"key":"BFonc2013320_CR19","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00109-007-0165-6","volume":"85","author":"RW Scott","year":"2007","unstructured":"Scott RW, Olson MF . LIM kinases: function, regulation and association with human disease. J Mol Med (Berl) 2007; 85: 555\u2013568.","journal-title":"J Mol Med (Berl)"},{"key":"BFonc2013320_CR20","doi-asserted-by":"publisher","first-page":"52919","DOI":"10.1074\/jbc.M309334200","volume":"278","author":"T Yokoo","year":"2003","unstructured":"Yokoo T, Toyoshima H, Miura M, Wang Y, Iida KT, Suzuki H et al. p57Kip2 regulates actin dynamics by binding and translocating LIM-kinase 1 to the nucleus. J Biol Chem 2003; 278: 52919\u201352923.","journal-title":"J Biol Chem"},{"key":"BFonc2013320_CR21","doi-asserted-by":"publisher","first-page":"22093","DOI":"10.1074\/jbc.M201444200","volume":"277","author":"T Amano","year":"2002","unstructured":"Amano T, Kaji N, Ohashi K, Mizuno K . Mitosis-specific activation of LIM motif-containing protein kinase and roles of cofilin phosphorylation and dephosphorylation in mitosis. J Biol Chem 2002; 277: 22093\u201322102.","journal-title":"J Biol Chem"},{"key":"BFonc2013320_CR22","doi-asserted-by":"publisher","first-page":"4983","DOI":"10.1074\/jbc.M708644200","volume":"283","author":"N Kaji","year":"2008","unstructured":"Kaji N, Muramoto A, Mizuno K . LIM kinase-mediated cofilin phosphorylation during mitosis is required for precise spindle positioning. J Biol Chem 2008; 283: 4983\u20134992.","journal-title":"J Biol Chem"},{"key":"BFonc2013320_CR23","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.yexcr.2005.12.030","volume":"312","author":"T Sumi","year":"2006","unstructured":"Sumi T, Hashigasako A, Matsumoto K, Nakamura T . Different activity regulation and subcellular localization of LIMK1 and LIMK2 during cell cycle transition. Exp Cell Res 2006; 312: 1021\u20131030.","journal-title":"Exp Cell Res"},{"key":"BFonc2013320_CR24","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/onc.2009.367","volume":"29","author":"ST Po\u2019uha","year":"2010","unstructured":"Po\u2019uha ST, Shum MS, Goebel A, Bernard O, Kavallaris M . LIM-kinase 2, a regulator of actin dynamics, is involved in mitotic spindle integrity and sensitivity to microtubule-destabilizing drugs. Oncogene 2010; 29: 597\u2013607.","journal-title":"Oncogene"},{"key":"BFonc2013320_CR25","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s00018-012-1073-7","volume":"70","author":"AS Nikonova","year":"2013","unstructured":"Nikonova AS, Astsaturov I, Serebriiskii IG, Dunbrack RL Jr., Golemis EA . Aurora A kinase (AURKA) in normal and pathological cell division. Cell Mol Life Sci 2013; 70: 661\u2013687.","journal-title":"Cell Mol Life Sci"},{"key":"BFonc2013320_CR26","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1242\/jcs.013136","volume":"120","author":"AR Barr","year":"2007","unstructured":"Barr AR, Gergely F . Aurora-A: the maker and breaker of spindle poles. J Cell Sci 2007; 120: 2987\u20132996.","journal-title":"J Cell Sci"},{"key":"BFonc2013320_CR27","doi-asserted-by":"publisher","first-page":"296","DOI":"10.4161\/cc.11.2.18734","volume":"11","author":"L Ritchey","year":"2012","unstructured":"Ritchey L, Ottman R, Roumanos M, Chakrabarti R . A functional cooperativity between Aurora A kinase and LIM kinase1: implication in the mitotic process. Cell Cycle 2012; 11: 296\u2013309.","journal-title":"Cell Cycle"},{"key":"BFonc2013320_CR28","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1242\/jcs.092304","volume":"125","author":"EO Johnson","year":"2012","unstructured":"Johnson EO, Chang KH, Ghosh S, Venkatesh C, Giger K, Low PS et al. LIMK2 is a crucial regulator and effector of Aurora-A-kinase-mediated malignancy. J Cell Sci 2012; 125: 1204\u20131216.","journal-title":"J Cell Sci"},{"key":"BFonc2013320_CR29","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1002\/ijc.21650","volume":"118","author":"R Bagheri-Yarmand","year":"2006","unstructured":"Bagheri-Yarmand R, Mazumdar A, Sahin AA, Kumar R . LIM kinase 1 increases tumor metastasis of human breast cancer cells via regulation of the urokinase-type plasminogen activator system. Int J Cancer 2006; 118: 2703\u20132710.","journal-title":"Int J Cancer"},{"key":"BFonc2013320_CR30","doi-asserted-by":"publisher","first-page":"6013","DOI":"10.1074\/jbc.M706538200","volume":"283","author":"Y Horita","year":"2008","unstructured":"Horita Y, Ohashi K, Mukai M, Inoue M, Mizuno K . Suppression of the invasive capacity of rat ascites hepatoma cells by knockdown of Slingshot or LIM kinase. J Biol Chem 2008; 283: 6013\u20136021.","journal-title":"J Biol Chem"},{"key":"BFonc2013320_CR31","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1593\/neo.04514","volume":"7","author":"I Okamoto","year":"2005","unstructured":"Okamoto I, Pirker C, Bilban M, Berger W, Losert D, Marosi C et al. Seven novel and stable translocations associated with oncogenic gene expression in malignant melanoma. Neoplasia 2005; 7: 303\u2013311.","journal-title":"Neoplasia"},{"key":"BFonc2013320_CR32","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/1476-4598-10-75","volume":"10","author":"BV McConnell","year":"2011","unstructured":"McConnell BV, Koto K, Gutierrez-Hartmann A . Nuclear and cytoplasmic LIMK1 enhances human breast cancer progression. Mol Cancer 2011; 10: 75.","journal-title":"Mol Cancer"},{"key":"BFonc2013320_CR33","doi-asserted-by":"publisher","first-page":"543","DOI":"10.2174\/156800912800673266","volume":"12","author":"F Manetti","year":"2012","unstructured":"Manetti F . Recent findings confirm LIM domain kinases as emerging target candidates for cancer therapy. Curr Cancer Drug Targets 2012; 12: 543\u2013560.","journal-title":"Curr Cancer Drug Targets"},{"key":"BFonc2013320_CR34","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1101\/gad.14.13.1617","volume":"14","author":"M Giovannini","year":"2000","unstructured":"Giovannini M, Robanus-Maandag E, van der Valk M, Niwa-Kawakita M, Abramowski V, Goutebroze L et al. Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2. Genes Dev 2000; 14: 1617\u20131630.","journal-title":"Genes Dev"},{"key":"BFonc2013320_CR35","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.1158\/1535-7163.MCT-08-0826","volume":"11","author":"P Ross-Macdonald","year":"2008","unstructured":"Ross-Macdonald P, de Silva H, Guo Q, Xiao H, Hung CY, Penhallow B et al. Identification of a nonkinase target mediating cytotoxicity of novel kinase inhibitors. Mol Cancer Ther 2008; 11: 3490\u20133498.","journal-title":"Mol Cancer Ther"},{"key":"BFonc2013320_CR36","first-page":"475","volume":"20","author":"G Hung","year":"2002","unstructured":"Hung G, Li X, Faudoa R, Xeu Z, Kluwe L, Rhim JS et al. Establishment and characterization of a schwannoma cell line from a patient with neurofibromatosis 2. Int J Oncol 2002; 20: 475\u2013482.","journal-title":"Int J Oncol"},{"key":"BFonc2013320_CR37","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/31729","volume":"393","author":"S Arber","year":"1998","unstructured":"Arber S, Barbayannis FA, Hanser H, Schneider C, Stanyon CA, Bernard O et al. Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase. Nature 1998; 393: 805\u2013809.","journal-title":"Nature"},{"key":"BFonc2013320_CR38","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1128\/MCB.22.4.1150-1157.2002","volume":"22","author":"AM Bashour","year":"2002","unstructured":"Bashour AM, Meng JJ, Ip W, MacCollin M, Ratner N . The neurofibromatosis type 2 gene product, merlin, reverses the F-actin cytoskeletal defects in primary human schwannoma cells. Mol Cell Biol 2002; 22: 1150\u20131157.","journal-title":"Mol Cell Biol"},{"key":"BFonc2013320_CR39","doi-asserted-by":"publisher","first-page":"5284","DOI":"10.1523\/JNEUROSCI.6207-11.2012","volume":"32","author":"N Sparrow","year":"2012","unstructured":"Sparrow N, Manetti ME, Bott M, Fabianac T, Petrilli A, Bates ML et al. The actin-severing protein cofilin is downstream of neuregulin signaling and is essential for Schwann cell myelination. J Neurosci 2012; 32: 5284\u20135297.","journal-title":"J Neurosci"},{"key":"BFonc2013320_CR40","doi-asserted-by":"publisher","first-page":"8013","DOI":"10.1074\/jbc.M109.098665","volume":"285","author":"MC Cote","year":"2010","unstructured":"Cote MC, Lavoie JR, Houle F, Poirier A, Rousseau S, Huot J . Regulation of vascular endothelial growth factor-induced endothelial cell migration by LIM kinase 1-mediated phosphorylation of annexin 1. J Biol Chem 2010; 285: 8013\u20138021.","journal-title":"J Biol Chem"},{"key":"BFonc2013320_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mcn.2010.12.006","volume":"47","author":"C Thaxton","year":"2011","unstructured":"Thaxton C, Bott M, Walker B, Sparrow NA, Lambert S, Fernandez-Valle C . Schwannomin\/merlin promotes Schwann cell elongation and influences myelin segment length. Mol Cell Neurosci 2011; 47: 1\u20139.","journal-title":"Mol Cell Neurosci"},{"key":"BFonc2013320_CR42","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1002\/glia.20578","volume":"55","author":"J Iacovelli","year":"2007","unstructured":"Iacovelli J, Lopera J, Bott M, Baldwin E, Khaled A, Uddin N et al. Serum and forskolin cooperate to promote G1 progression in Schwann cells by differentially regulating cyclin D1, cyclin E1, and p27Kip expression. Glia 2007; 55: 1638\u20131647.","journal-title":"Glia"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2013320.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2013320","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2013320.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T19:33:57Z","timestamp":1647891237000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2013320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,12]]},"references-count":42,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2014,7,3]]}},"alternative-id":["BFonc2013320"],"URL":"https:\/\/doi.org\/10.1038\/onc.2013.320","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,12]]},"assertion":[{"value":"6 March 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}